Accendra Health Inc. Share Price ACH

$3.65

▲

0.06

(1.67%)

Last updated on July 7, 2026 at 1:29 am IST

$₹

Check the interactive Accendra Health Inc. Stock chart to analyse performance

Accendra Health, Inc. Key Stats

Check Accendra Health Inc. key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$3.59
Today's High	$3.725
Today's Low	$3.44
Market Capitalization	$274.9M
Revenue TTM	$2.7B
EBITDA	$323.7M
Earnings Per Share (EPS)	$-1.37
Profit Margin	-39.84%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-198.35%

Stock Returns calculator for Accendra Health Inc. Stock including INR - Dollar returns

The Accendra Health Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Accendra Health Inc. investment value today

Current value as on today

Returns

(0%)

Returns from Accendra Health Inc. Stock

(0%)

Dollar Impact

(0%)

Indian investors sentiment towards Accendra Health Inc. Stock

85%

Period: Jun 6, 2026 to Jul 6, 2026. Change in 30 Days versus previous period

Search interest for Accendra Health Inc. Stock from India on INDmoney has increased by 85% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Accendra Health, Inc.

Name
Holdings %
Name
Holdings %
Coliseum Capital Management LLC
17.11%
Vanguard Group Inc
8.25%
BlackRock Inc
6.84%
Charles Schwab Investment Management Inc
4.75%
Bank of America Corp
4.45%
Invenomic Capital Management, LP
4.40%

Analyst Recommendation on Accendra Health Inc. Stock

Rating

Trend

Buy

66%Buy

20%Hold

13%Sell

Based on 15 Wall street analysts offering stock ratings for Accendra Health Inc.(by analysts ranked 0 to 5 stars)

Accendra Health Inc. Share Price Target

What analysts predicted

Upside of 23.01%

Target:

$4.49

Current:

$3.65

Accendra Health Inc. share price target is $4.49, a slight Upside of 23.01% compared to current price of $3.65 as per analysts' prediction.

Accendra Health Inc. Stock Insights

Price Movement
In the last 1 month, ACH stock has moved up by 33.0%
Decreasing Revenue
Revenue is down for the last 2 quarters, 708.96M → 627.78M (in $), with an average decrease of 11.5% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -869.05M → -6.46M (in $), with an average increase of 472.0% per quarter

Accendra Health, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY16

FY17

FY18

FY19

FY20

FY21

FY22

FY23

FY24

FY25

	FY16	Y/Y Change
Revenue	$9.7B	-
Net Income	$108.8M	-
Net Profit Margin	1.12%	-

	FY17	Y/Y Change
Revenue	$9.3B	↓ 4.17%
Net Income	$72.8M	↓ 33.09%
Net Profit Margin	0.78%	↓ 0.34%

	FY18	Y/Y Change
Revenue	$9.4B	↑ 1.07%
Net Income	$-437.0M	↓ 700.35%
Net Profit Margin	-4.64%	↓ 5.42%

	FY19	Y/Y Change
Revenue	$9.2B	↓ 2.2%
Net Income	$-62.4M	↓ 85.73%
Net Profit Margin	-0.68%	↑ 3.96%

	FY20	Y/Y Change
Revenue	$8.5B	↓ 7.93%
Net Income	$29.9M	↓ 147.89%
Net Profit Margin	0.35%	↑ 1.03%

	FY21	Y/Y Change
Revenue	$9.8B	↑ 15.39%
Net Income	$221.6M	↑ 641.82%
Net Profit Margin	2.26%	↑ 1.91%

	FY22	Y/Y Change
Revenue	$10.0B	↑ 1.74%
Net Income	$22.4M	↓ 89.9%
Net Profit Margin	0.22%	↓ 2.04%

	FY23	Y/Y Change
Revenue	$10.3B	↑ 3.8%
Net Income	$-41.3M	↓ 284.47%
Net Profit Margin	-0.4%	↓ 0.62%

	FY24	Y/Y Change
Revenue	$10.7B	↑ 3.55%
Net Income	$-362.7M	↑ 778.15%
Net Profit Margin	-3.39%	↓ 2.99%

	FY25	Y/Y Change
Revenue	$2.8B	↓ 74.19%
Net Income	$-1.1B	↑ 203.47%
Net Profit Margin	-39.85%	↓ 36.46%

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

Q1 FY26

	Q4 FY23	Q/Q Change
Revenue	$2.7B	-
Net Income	$17.8M	-
Net Profit Margin	0.67%	-

	Q1 FY24	Q/Q Change
Revenue	$2.6B	↓ 1.64%
Net Income	$-21.9M	↓ 223.07%
Net Profit Margin	-0.84%	↓ 1.51%

	Q2 FY24	Q/Q Change
Revenue	$660.4M	↓ 74.72%
Net Income	$-31.9M	↑ 45.81%
Net Profit Margin	-4.83%	↓ 3.99%

	Q3 FY24	Q/Q Change
Revenue	$686.8M	↑ 4.0%
Net Income	$-12.8M	↓ 59.98%
Net Profit Margin	-1.86%	↑ 2.97%

	Q4 FY24	Q/Q Change
Revenue	$2.7B	↑ 292.53%
Net Income	$-296.1M	↑ 2218.84%
Net Profit Margin	-10.98%	↓ 9.12%

	Q1 FY25	Q/Q Change
Revenue	$2.6B	↓ 2.37%
Net Income	$-25.0M	↓ 91.56%
Net Profit Margin	-0.95%	↑ 10.03%

	Q2 FY25	Q/Q Change
Revenue	$681.9M	↓ 74.09%
Net Income	$-869.1M	↑ 3378.74%
Net Profit Margin	-127.44%	↓ 126.49%

	Q3 FY25	Q/Q Change
Revenue	$697.3M	↑ 2.25%
Net Income	$-150.3M	↓ 82.71%
Net Profit Margin	-21.55%	↑ 105.89%

	Q4 FY25	Q/Q Change
Revenue	$709.0M	↑ 1.68%
Net Income	$-56.3M	↓ 62.52%
Net Profit Margin	-7.94%	↑ 13.61%

	Q1 FY26	Q/Q Change
Revenue	$627.8M	↓ 11.45%
Net Income	$-6.5M	↓ 88.52%
Net Profit Margin	-1.03%	↑ 6.91%

FY16

FY17

FY18

FY19

FY20

FY21

FY22

FY23

FY24

FY25

	FY16	Y/Y Change
Profit	$1.2B	-

	FY17	Y/Y Change
Profit	$1.2B	↓ 1.3%

	FY18	Y/Y Change
Profit	$1.1B	↓ 8.65%

	FY19	Y/Y Change
Profit	$1.1B	↑ 5.41%

	FY20	Y/Y Change
Profit	$1.3B	↑ 13.5%

	FY21	Y/Y Change
Profit	$1.5B	↑ 18.14%

	FY22	Y/Y Change
Profit	$1.8B	↑ 20.69%

	FY23	Y/Y Change
Profit	$2.1B	↑ 16.36%

	FY24	Y/Y Change
Profit	$2.2B	↑ 4.42%

	FY25	Y/Y Change
Profit	$1.3B	↓ 41.9%

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

Q1 FY26

	Q4 FY23	Q/Q Change
Profit	$569.9M	-

	Q1 FY24	Q/Q Change
Profit	$535.5M	↓ 6.03%

	Q2 FY24	Q/Q Change
Profit	$316.0M	↓ 40.99%

	Q3 FY24	Q/Q Change
Profit	$331.8M	↑ 4.98%

	Q4 FY24	Q/Q Change
Profit	$579.8M	↑ 74.75%

	Q1 FY25	Q/Q Change
Profit	$526.0M	↓ 9.27%

	Q2 FY25	Q/Q Change
Profit	$324.6M	↓ 38.29%

	Q3 FY25	Q/Q Change
Profit	$322.2M	↓ 0.74%

	Q4 FY25	Q/Q Change
Profit	$323.3M	↑ 0.33%

	Q1 FY26	Q/Q Change
Profit	$278.0M	↓ 13.99%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Operating Cash Flow	$339.2M	↑ 104.25%
Investing Cash Flow	$80.1M	↓ 254.29%
Financing Cash Flow	$-379.4M	↑ 191.39%

	FY21	Y/Y Change
Operating Cash Flow	$124.2M	↓ 63.39%
Investing Cash Flow	$-53.6M	↓ 166.98%
Financing Cash Flow	$-129.5M	↓ 65.87%

	FY22	Y/Y Change
Operating Cash Flow	$325.0M	↑ 161.73%
Investing Cash Flow	$-1.8B	↑ 3264.68%
Financing Cash Flow	$1.5B	↓ 1256.26%

	FY23	Y/Y Change
Operating Cash Flow	$740.7M	↑ 127.91%
Investing Cash Flow	$-137.3M	↓ 92.39%
Financing Cash Flow	$-417.3M	↓ 127.88%

	FY24	Y/Y Change
Operating Cash Flow	$161.5M	↓ 78.2%
Investing Cash Flow	$-116.5M	↓ 15.1%
Financing Cash Flow	$-267.6M	↓ 35.88%

	FY25	Y/Y Change
Operating Cash Flow	$-101.8M	↓ 163.03%
Investing Cash Flow	$144.4M	↓ 223.93%
Financing Cash Flow	$188.1M	↓ 170.28%

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

Q1 FY26

	Q4 FY24	Q/Q Change
Operating Cash Flow	$71.0M	↑ 160.01%
Investing Cash Flow	$-52.3M	↑ 92.37%
Financing Cash Flow	$-43.1M	↓ 78.41%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-35.1M	↓ 149.39%
Investing Cash Flow	$-48.2M	↓ 7.85%
Financing Cash Flow	$92.8M	↓ 315.28%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$37.6M	↓ 207.25%
Investing Cash Flow	$-52.9M	↑ 9.79%
Financing Cash Flow	$31.7M	↓ 65.83%

	Q1 FY26	Q/Q Change
Operating Cash Flow	$-50.1M	↓ 173.44%
Investing Cash Flow	$53.9M	↓ 81.08%
Financing Cash Flow	$51.1M	↓ 143.48%

Accendra Health Inc. Technicals Summary

Sell

Neutral

Buy

Accendra Health Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Accendra Health, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Accendra Health, Inc.	40.78%	87.96%	54.74%	54.74%	-74.28%
Cardinal Health, Inc.	16.85%	14.61%	42.54%	155.03%	322.01%
Cencora, Inc.	8.18%	-14.35%	-1.98%	65.74%	116.57%
McKesson Corporation	2.56%	-4.87%	6.93%	89.58%	316.98%
Henry Schein, Inc. Common Stock	10.74%	10.03%	17.67%	7.98%	14.05%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Accendra Health, Inc.	NA	NA	0.7	0.42	-1.98	0.02	NA	-6.07
Cardinal Health, Inc.	36.48	36.48	1.48	10.77	0.0	0.04	0.01	-12.05
Cencora, Inc.	22.72	22.72	0.63	17.77	1.07	0.03	0.01	17.46
McKesson Corporation	20.49	20.49	1.54	39.01	0.0	0.05	0.0	-18.1
Henry Schein, Inc. Common Stock	26.11	26.11	1.84	5.35	0.09	0.04	NA	28.54

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Accendra Health, Inc.	Buy	$274.9M	-74.28%	NA	-39.84%
Cardinal Health, Inc.	Hold	$56.0B	322.01%	36.48	0.62%
Cencora, Inc.	Buy	$57.7B	116.57%	22.72	0.78%
McKesson Corporation	Buy	$92.1B	316.98%	20.49	1.18%
Henry Schein, Inc. Common Stock	Hold	$9.8B	14.05%	26.11	2.95%

About Accendra Health, Inc.

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Organization	Accendra Health Inc.
Employees	6500
CEO	Mr. Edward A. Pesicka
Industry	Healthcare

Key Management of Accendra Health, Inc.

Name	Title
Mr. Edward A. Pesicka	President, CEO & Director
Mr. Jonathan A. Leon	Executive VP, CFO & Corporate Treasurer
Mr. Perry A. Bernocchi	Executive VP & COO
Mr. Heath H. Galloway	Executive VP, General Counsel & Corporate Secretary
Will Parrish	Vice President of Strategy of Corporate Development, & Investor Relations
Mr. Dirk Benson	Chief Commercial Officer
Mr. Colin Bain	Chief Products Officer
Trudi Allcott	Director of Media Relations

Important FAQs about investing in ACH Stock from India :

What is Accendra Health Inc. share price today?

Accendra Health Inc. share price today is $3.65 as on July 7, 2026 at 1:29 am IST at the close of the market. Accendra Health Inc. share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Accendra Health Inc. share?

Accendra Health Inc. share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Accendra Health Inc. stock price today i.e. July 7, 2026 at 1:29 am IST is closed at $3.65, lower by 0% versus the 52 week high.

How to invest in Accendra Health Inc. Stock (ACH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Accendra Health Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Accendra Health Inc. Shares that will get you 0.4110 shares as per Accendra Health Inc. share price of $3.65 per share as on July 7, 2026 at 1:29 am IST.

What is the minimum amount required to buy Accendra Health Inc. Stock (ACH) from India?

Indian investors can start investing in Accendra Health Inc. (ACH) shares with as little as ₹95.395 or $1 (as of July 07, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹953.95 in Accendra Health Inc. stock (as per the Rupee-Dollar exchange rate as on July 07, 2026). Based on Accendra Health Inc. share’s latest price of $3.65 as on July 7, 2026 at 1:29 am IST, you will get 2.7397 shares of Accendra Health Inc.. Learn more about fractional shares .

What are the returns that Accendra Health Inc. has given to Indian investors in the last 5 years?

Accendra Health Inc. stock has given -74.28% share price returns and 28.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?

Discover More

Damora Therapeutics, Inc. Common Stock
$29.78
-0.67%
Aktis Oncology, Inc. Common stock
$26.72
-15.87%
SpyGlass Pharma, Inc. Common Stock
$19.14
-0.05%
Mobia Medical, Inc. Common Stock
$13.36
-2.12%
Conexeu Sciences Inc. Common Stock
$10.80
-0.55%
Glass House Brands Inc.
$11.33
-9.36%
Faeth Therapeutics, Inc. Common Stock
$24.36
+6.28%
Regentis Biomaterials Ltd.
$3.93
-2.48%
Eikon Therapeutics, Inc. Common Stock
$12.05
-3.91%

Explore all

	Q3 FY25	Q/Q Change
Operating Cash Flow	$-172.5M	↓ 558.71%
Investing Cash Flow	$-39.5M	↓ 25.42%
Financing Cash Flow	$181.1M	↑ 471.3%

	Q4 FY25	Q/Q Change
Operating Cash Flow	$68.2M	↓ 139.52%
Investing Cash Flow	$285.0M	↓ 822.19%
Financing Cash Flow	$-117.5M	↓ 164.88%

Accendra Health Inc. Share Price ACH

Accendra Health, Inc. Key Stats

Stock Returns calculator for Accendra Health Inc. Stock including INR - Dollar returns

Indian investors sentiment towards Accendra Health Inc. Stock

Global Institutional Holdings in Accendra Health, Inc.

Analyst Recommendation on Accendra Health Inc. Stock

Accendra Health Inc. Share Price Target

Accendra Health Inc. Stock Insights

Price Movement

Decreasing Revenue

Increasing Net Profit

Accendra Health, Inc. Financials

Accendra Health Inc. Technicals Summary

Accendra Health, Inc. Vs Peers

About Accendra Health, Inc.

Key Management of Accendra Health, Inc.

Important FAQs about investing in ACH Stock from India :

What is Accendra Health Inc. share price today?

What is the 52 week high and 52 week low for Accendra Health Inc. share?

How to invest in Accendra Health Inc. Stock (ACH) from India?

What is the minimum amount required to buy Accendra Health Inc. Stock (ACH) from India?

What are the returns that Accendra Health Inc. has given to Indian investors in the last 5 years?

Discover More